Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Gillette's CranioCap:

This article was originally published in Clinica

Executive Summary

US hospital Gillette Children's Speciality Healthcare has received FDA 510(k) clearance to market its CranioCap cranial brace for the treatment of deformational plagiocephaly (a miss-shapen head) in infants. The custom-made device works by applying passive pressure to prominent regions of the cranium, redirecting its growth to recessed areas in the brace to improve cranial symmetry and/or shape. The CranioCap is worn for three to four hours at a time and it takes three to four months for adequate change to take place, said the St Paul, Minnesota hospital.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075358

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel